BSE Sensex, Nifty gain; IIP data eyed

Thu Apr 12, 2012 10:11am IST

People walk past the Bombay Stock Exchange (BSE) building in Mumbai January 9, 2009. REUTERS/Punit Paranjpe/Files

People walk past the Bombay Stock Exchange (BSE) building in Mumbai January 9, 2009.

Credit: Reuters/Punit Paranjpe/Files

Related Topics

Stocks

   

Reuters Market Eye - The BSE Sensex and Nifty rose as banks extended gains from the previous session on hopes for a cut in cash reserve ratio, while Larsen & Toubro(LART.NS) and other capital good stocks gained ahead of industrial output data later in the morning.

A rebound in U.S. markets overnight also helped overall risk sentiment after an encouraging start to the U.S. earnings season.

State Bank of India rose 2.1 percent as traders brace for the prospect the RBI will announce a cut in the CRR on, or before, its policy meeting on April 17 to ease a tight liquidity crunch in the sector.

L&T shares rose 1.3 percent ahead of the notoriously volatile industrial output data. A Reuters survey shows analysts expect industrial production to grow 6.6 percent in February from a year ago, slightly lower than in January.

The BSE Sensex was up 0.6 percent, while the Nifty gained 0.7 percent.

(Reporting by Manoj Dharra; Editing by Rafael Nam)

FILED UNDER:

Monetary Policy Committee

Reuters Showcase

Microfinance

Microfinance

Funding the unfunded: India helps small business borrow to grow  Full Article 

Insurance Sector

Insurance Sector

UK healthcare firm Bupa sees strong growth in India  Full Article 

Sensex Rises

Sensex Rises

Sensex edges up; consumer and healthcare stocks rise  Full Article 

Market Eye

Market Eye

FTSE adds nine Indian firms as large-caps in Asia-Pacific ex-Japan index   Full Article 

Indian Ocean Diplomacy

Indian Ocean Diplomacy

PM Modi to ramp up help for Indian Ocean nations to counter China influence  Full Article 

ECB Bond-Buying

ECB Bond-Buying

ECB raises growth forecasts, to start printing money next week  Full Article 

China Economy

China Economy

China signals "new normal" with lower annual growth target  Full Article 

Pharma Sector

Pharma Sector

Panel recommends waiving late-stage trials for some drugs  Full Article 

E-commerce

E-commerce

China backs e-commerce expansion in win for Alibaba, JD.com  Full Article 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device  Full Coverage